anyone telling you to buy this company since 2020 has resulted in loss of your money. I reckon the most valuable contribution I could have made for the last several years was to encourage redistribution of funds to better run businesses. It’s been hard watching the decline of Clinuvel but that hasn’t changed the facts of declining share price. The issues were easily identified; weak board, chairmen with no experience and close relationships to ceo, soirées, gifting of shares to maestros, no progress in the clinic, anemic growth, etc etc.
Ann: Preliminary results from SCENESSE adolescent EPP study, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.76 |
Change
-0.050(0.51%) |
Mkt cap ! $489.2M | |||
| Open | High | Low | Value | Volume |
| $9.90 | $10.00 | $9.76 | $618.8K | 62.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 195 | $9.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.89 | 351 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |